These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Sustained molecular response with interferon alfa maintenance after induction therapy with imatinib plus interferon alfa in patients with chronic myeloid leukemia. Burchert A; Müller MC; Kostrewa P; Erben P; Bostel T; Liebler S; Hehlmann R; Neubauer A; Hochhaus A J Clin Oncol; 2010 Mar; 28(8):1429-35. PubMed ID: 20142590 [TBL] [Abstract][Full Text] [Related]
8. Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatment. Riva G; Luppi M; Barozzi P; Quadrelli C; Basso S; Vallerini D; Zanetti E; Morselli M; Forghieri F; Maccaferri M; Volzone F; Del Giovane C; D'Amico R; Locatelli F; Torelli G; Comoli P; Potenza L Blood; 2010 Feb; 115(8):1512-8. PubMed ID: 20007806 [TBL] [Abstract][Full Text] [Related]
10. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. Joensuu H; Eriksson M; Sundby Hall K; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Monge OR; Bono P; Kallio R; Vehtari A; Leinonen M; Alvegård T; Reichardt P JAMA; 2012 Mar; 307(12):1265-72. PubMed ID: 22453568 [TBL] [Abstract][Full Text] [Related]
11. Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients. Ménard C; Blay JY; Borg C; Michiels S; Ghiringhelli F; Robert C; Nonn C; Chaput N; Taïeb J; Delahaye NF; Flament C; Emile JF; Le Cesne A; Zitvogel L Cancer Res; 2009 Apr; 69(8):3563-9. PubMed ID: 19351841 [TBL] [Abstract][Full Text] [Related]
12. Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib: a phase I-II study by the Spanish Group for Research on Sarcomas. Maurel J; Martins AS; Poveda A; López-Guerrero JA; Cubedo R; Casado A; Martínez-Trufero J; Ramón Ayuso J; Lopez-Pousa A; Garcia-Albeniz X; Garcia del Muro X; de Alava E Cancer; 2010 Aug; 116(15):3692-701. PubMed ID: 20564079 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy observation on imatinib reintroduction in gastrointestinal stromal tumor with high recurrence risk after imatinib adjuvant therapy failure]. Dong Z; Gao J; Gong J; Li J; Li Y; Wang X; Li Y; Shen L; Li J Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1286-1289. PubMed ID: 27928801 [TBL] [Abstract][Full Text] [Related]
14. PD-1/PD-L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K/Akt/mTOR signalling pathway. Zhao R; Song Y; Wang Y; Huang Y; Li Z; Cui Y; Yi M; Xia L; Zhuang W; Wu X; Zhou Y Cell Prolif; 2019 May; 52(3):e12571. PubMed ID: 30714229 [TBL] [Abstract][Full Text] [Related]
15. Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors. Rusakiewicz S; Semeraro M; Sarabi M; Desbois M; Locher C; Mendez R; Vimond N; Concha A; Garrido F; Isambert N; Chaigneau L; Le Brun-Ly V; Dubreuil P; Cremer I; Caignard A; Poirier-Colame V; Chaba K; Flament C; Halama N; Jäger D; Eggermont A; Bonvalot S; Commo F; Terrier P; Opolon P; Emile JF; Coindre JM; Kroemer G; Chaput N; Le Cesne A; Blay JY; Zitvogel L Cancer Res; 2013 Jun; 73(12):3499-510. PubMed ID: 23592754 [TBL] [Abstract][Full Text] [Related]
16. Effective salvage therapy of imatinib-resistant gastrointestinal stromal tumor with combination of imatinib and pegylated liposomal doxorubicin. Hsieh YY; Yen CC; Yeh CN; Tzen CY; Liu JH; Lee HJ; Teng HW; Tzeng CH; Chiou TJ; Chao TC J Chin Med Assoc; 2011 Jun; 74(6):272-4. PubMed ID: 21621171 [TBL] [Abstract][Full Text] [Related]
17. Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors. Blay JY; Pérol D; Le Cesne A Ann Oncol; 2012 Jul; 23(7):1659-65. PubMed ID: 22357253 [TBL] [Abstract][Full Text] [Related]
18. [A multicentre retrospective cohort study of patients with gastrointestinal stromal tumors in Shandong Province]. Ning L; Yan W; Zhang M; Gong H; Dai Y; Jiang L; Lin H; Zhang D; Zhou Y Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):326-30. PubMed ID: 24760638 [TBL] [Abstract][Full Text] [Related]
19. [A study to determine the safety and efficacy of imatinib mesylate in patients with chronic phase of chronic myeloid leukemia after interferon therapy failure. Four year follow-up]. Hołowiecki J; Konopka L; Bober G; Giebel S; Ceglarek B; Kos K; Stella-Hołowiecka B; Kruzel T; Kopera M; Bartkowska-Chrobok A; Pszenna E; Sikorska A; Pieńikowska-Grela B Pol Arch Med Wewn; 2006 Jun; 115(6):535-44. PubMed ID: 17263225 [TBL] [Abstract][Full Text] [Related]
20. [Treatment strategy for recurrent and metastatic gastrointestinal stromal tumors]. Liang H Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):309-11. PubMed ID: 24760634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]